278 publications
| Name | Date | Type | Actions |
|---|---|---|---|
2024 Annual results Annual sales: €539m (+2.2% at constant exchange rates) |
Public releases | ||
Annual sales 2024: €539 million Annual sales: €539 million (up 2.2% at constant exchange rates and up 1.9%. on a reported basis) |
Public releases | ||
Sales at end September 2024 At the end of September 2024, Vetoquinol sales totaled €398 million, up +1.6% on a reported basis and +1.8% at constant exchange rates. |
Public releases | ||
2024 half-year Results Sales: €264m (+3.2% as reported) |
Public releases | ||
2024 Annual General Assembly - results Results in French |
Shareholders´s Meeting | ||
Assemblée Générale Annuelle de Vetoquinol SA 28 mai 2024 Ordre du jour : |
Shareholders´s Meeting | ||
SALES 1st quarter 2024: €134M The Vetoquinol Group recorded sales of €133.7 million in the 1st quarter of fiscal 2024, including €83.4 million for Essential products. |
Public releases | ||
Availability of the 2023 universal registration document On 24 April 2024, Vetoquinol filed its 2022 Universal Registration Document with the Autorité des Marchés Financiers (AMF) in ESEF (European Single Electronic Format). |
Public releases | ||
BALO : Notice of meeting Shareholders are invited to attend the Combined General Meeting to be held on Tuesday May 28, 2024 at 11 a.m. at the Company's registered office, Magny-Vernois 70 200 LURE, in order to deliberate on the following agenda and draft resolutions |
Shareholders´s Meeting | ||
2023 ANNUAL RESULTS Annual sales: €529m (stable at constant exchange rates) |
Public releases |